IHH Annual Report 2024

Financial Statements Notes to the Financial Statements 32. FINANCIAL INSTRUMENTS (continued) (v) Liquidity risk (continued) Maturity analysis (continued) Carrying amount Contractual cash flows Within 1 year After 1 year but within 5 years After 5 years Group RM’mil RM’mil RM’mil RM’mil RM’mil 2023 Non-derivative financial liabilities Bank overdrafts 78 78 78 – – Loans and borrowings 8,312 9,445 1,944 7,015 486 Lease liabilities 1,661 3,420 411 1,381 1,628 Trade and other payables* 5,164 5,660 4,774 836 50 15,215 18,603 7,207 9,232 2,164 Derivative financial instruments Foreign exchange forward contracts (gross-settled) (60) − inflows (1,103) (767) (324) (12) − outflows 1,020 713 296 11 Cross currency interest rate swaps (gross-settled) (84) − inflows (373) (51) (322) – − outflows 287 – 287 – Cross currency swaps (gross-settled) (192) − inflows (247) (247) – – − outflows 63 63 – – Interest rate swaps (net-settled) 9 9 1 6 2 Interest rate caps (net-settled) (4) (4) – (4) – (331) (348) (288) (61) 1 14,884 18,255 6,919 9,171 2,165 * Excludes deposits, rental advance billings and contract liabilities. IHH Healthcare Berhad | Annual Report 2024 198

RkJQdWJsaXNoZXIy NDgzMzc=